Product: MethyLPREDNISolone Acetate Injectable Suspension USP, 400 mg/5mL (80 mg/mL), 5 mL multi-dose vials, Rx only, MFG: Teva Pharma USA, NDC 0703-0063-01
Reason for recall: cGMP deviations: Temperature abuse
Recall initiated: 20220413
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated